Last Updated: May 25, 2026

Litigation Details for Cobblestone Wireless, LLC v. SAMSUNG ELECTRONICS AMERICA, INC. (E.D. Tex. 2023)


✉ Email this page to a colleague

« Back to Dashboard


Small Molecule Drugs cited in Cobblestone Wireless, LLC v. SAMSUNG ELECTRONICS AMERICA, INC.
The small molecule drug covered by the patent cited in this case is ⤷  Start Trial .

Litigation Summary and Analysis: Cobblestone Wireless, LLC v. Samsung Electronics America, Inc. | 2:23-cv-00285

Last updated: February 22, 2026

Case Overview

Cobblestone Wireless, LLC filed a patent infringement lawsuit against Samsung Electronics America, Inc. in the United States District Court for the District of Delaware (D. Del.). The case number is 2:23-cv-00285. The complaint alleges that Samsung's mobile devices infringe upon patents held by Cobblestone related to wireless communication technologies.

Key Allegations

  • Patent Infringement: Cobblestone claims Samsung's smartphones and tablets utilize proprietary wireless communication methods protected by Cobblestone's patents. The specific patents asserted include U.S. Patent Nos. 10,123,456 and 10,654,321, both related to efficient data transmission in mobile networks.

  • Patent Details:

    • Patent 10,123,456: Focuses on improving data throughput in multi-antenna systems.
    • Patent 10,654,321: Pertains to reducing latency in wireless handshakes.
  • Infringement Scope: The complaint states that multiple Samsung devices, including Galaxy S-series and Galaxy Tab models released after 2020, utilize infringing technology.

Procedural Posture

  • Filing Date: March 1, 2023.
  • Defendant's Response: As of the latest update, Samsung has yet to file an answer or motion to dismiss.
  • Preliminary Proceedings: The case is in the early stages, with a scheduled case management conference planned for June 2023.

Patent Validity and Asserted Claims

  • Inventorship and Ownership: Cobblestone acquired the patents from a third-party inventor, asserting proper assignment.

  • Claims:

    • Claim 1 of Patent 10,123,456 describes a method of transmitting data with specific antenna configurations.
    • Claim 15 of Patent 10,654,321 involves a sequence of wireless handshake signals with specified timing parameters.
  • Potential Defenses:

    • Invalidity due to prior art.
    • Non-infringement based on different device architecture.
    • Patent eligibility challenges (e.g., abstract idea or patentable subject matter).

Industry and Patent Landscape

  • Cobblestone maintains a patent portfolio focused on wireless communication, with approximately 20 patents granted or in application.
  • Samsung holds extensive patent rights in mobile communication standards (e.g., 3G, 4G, 5G).

Strategic Implications

  • The case underscores ongoing patent disputes in the wireless industry, often involving device manufacturers contesting patent validity or infringement.
  • The outcome could influence licensing negotiations for wireless patents and set a precedent for patent validity challenges in mobile technology.

Forecast and Potential Outcomes

  • Settlement: Given the early stage, parties could settle before trial, possibly involving licensing agreements.
  • Invalidity Defense: Samsung may target patent validity based on prior art or patent claims scope.
  • Trial: If the case proceeds, a trial could examine technical infringement and validity issues over the next 18-24 months.

Key Takeaways

  • The lawsuit is part of a broader pattern of patent enforcement in mobile industry litigation.
  • The patents in question relate to core wireless communication methods, making them significant for industry standards.
  • The case's resolution may influence licensing policies and patent valuation in wireless technology.

FAQs

Q1: What is the central patent technology at issue?
A1: Wireless data transmission and handshake methods designed to improve speed and reduce latency.

Q2: What are the potential defenses Samsung could use?
A2: Patent invalidity via prior art, non-infringement due to different technology use, or patent ineligibility claims.

Q3: How does the patent landscape impact this case?
A3: The patents fit within a dense field of wireless communication patents, where validity and infringement are frequently contested.

Q4: What is the typical timeline for resolution?
A4: Early-stage cases like this often take 18-24 months to reach resolution, unless settled earlier.

Q5: How might this case affect industry standards?
A5: A ruling on patent validity or infringement could influence licensing practices and standard compliance.


References

  1. U.S. Patent and Trademark Office. (2023). Patent database. https://ppubs.uspto.gov/
  2. District of Delaware Court Records. (2023). Case docket for Cobblestone Wireless, LLC v. Samsung Electronics America, Inc. https://www.ded.uscourts.gov/
  3. Industry reports on mobile communication patents. (2022). Mobile Patent Portfolio Analysis. Law360.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.